GGT in NAFLD / MASH (Metabolic-Associated Steatohepatitis)

Elevated. Studies summarised in the OSMF atlas report higher GGT in NAFLD / MASH (Metabolic-Associated Steatohepatitis) than in the reference group of the cited comparison (NAFLD with elevated inflammatory activity vs lower GGT levels). Source: Liang et al. 2023.

The atlas record does not list a standardised clinical test code (LOINC) for GGT, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

No. No single biomarker is diagnostic of NAFLD / MASH (Metabolic-Associated Steatohepatitis). GGT findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.